ERBB2 Increases Metastatic Potentials Specifically in Androgen-Insensitive Prostate Cancer Cells

Despite all the blood-based biomarkers used to monitor prostate cancer patients, prostate cancer remains as the second common cause of cancer mortality in men in the United States. This is largely due to a lack of understanding of the molecular pathways that are responsible for the aggressive forms...

Descripción completa

Detalles Bibliográficos
Autores principales: Tome-Garcia, Jessica, Li, Dan, Ghazaryan, Seda, Shu, Limin, Wu, Lizhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061020/
https://www.ncbi.nlm.nih.gov/pubmed/24937171
http://dx.doi.org/10.1371/journal.pone.0099525

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061020/
https://www.ncbi.nlm.nih.gov/pubmed/24937171
http://dx.doi.org/10.1371/journal.pone.0099525

Ejemplares similares